flabio5

Ompi EZ-fill® ISS: an Integrated Safety System for Prefilled Syringes

Sep 1, 2017

Ompi expands its Ompi EZ-fill® Syringes offer by adding up an Integrated Safety System (ISS) for staked needle syringes. Ompi EZ-fill® ISS is an innovative fully passive safety system designed to guarantee end users’ safety and reduce total cost of ownership for the pharmaceutical companies. Ompi EZ-fill® ISS is the first development within the platform licensed by Tip-Top, a primary designer of proprietary safety needlestick protection devices and technologies. Based on their mini-Max design, Ompi EZ-fill® ISS avoids piercing after rubber needle shield removal, providing an end-user experience similar to a standard syringe. “Ompi EZ-fill® Integrated Safety Systems (ISS) is ...

Read More

Ompi and Balda are pleased to announce that they will be exhibiting at CPhI Worldwide 2017 at Messe Frankfurt (24th-26th October), at Booth 42H12!

Sep 1, 2017

Ompi is part of the Pharmaceutical Systems division of Stevanato Group. It boasts a unique expertise in providing superior pharmaceutical containers from glass-tubing. Its comprehensive portfolio covers every customer needs, from those related to small molecules to highly sensitive drugs: syringes, pen and dental cartridges, injection and lyophilization vials and ampoules. Syringes, cartridges and vials are produced both in bulk and sterile format (EZ-fillTM). Ompi also provides customized glass containers, all manufactured to the highest standards. Balda is one of the leading global worldwide manufacturers customized healthcare products made of plastics. It provides life cycle competence from product design, development, ...

Read More

Jesper Ericsson appointed new CEO of Symcel

Sep 1, 2017

Symcel Sverige AB today announces the appointment of Jesper Ericsson as new Chief Executive Officer – succeeding Christer Wallin who is now retiring   1 September 2017: Symcel has today announced that Jesper Ericsson has joined Symcel as Chief Executive Officer – with the appointment effective immediately. Ericsson was formally Director of Marketing and Sales at BioLamina AB, where he was responsible for direct sales both internationally and at a global and regional distributor level. During the past 10 years, Jesper has gained broad experience of the commercialization of research-based products through his work at the Unit for Bioentrepreneurship at the ...

Read More

ADCs and BIOSIMILARS: The development towards a new generation of targeted therapies

Aug 25, 2017

Antibodies-based therapeutics are perhaps the most successful and versatile drug approach developed in the last 30 years. They not only have found application as vaccines and drug carriers but have also been applied to analytical methods such as ELISA (Enzyme-linked Immunosorbent Assay), Wester blotting and flow cytometry. The discovery of the smallpox vaccine by Jenner in the late 1700s certainly represents the paradigm shift for the most disparate applications of antibodies currently available in the biomedical market. Antibodies have evolved considerably from early stages and now are developed as the new generation – called Biobetter – which aim to minimise ...

Read More

Qatar Airways Cargo and DoKaSch sign master agreement OPTICOOLER® ACTIVE CONTAINER NOW AVAILABLE FOR PHARMA SHIPMENTS

Aug 25, 2017

DoKaSch Temperature Solutions, provider of climate-controlled solutions for air shipment of temperature-sensitive cargo, expands its customer base by signing an agreement with Qatar Airways Cargo. This enables customers to directly lease the newest technology of Active Containers, RKN and RAP Opticooler®, from Qatar Airways Cargo all around the globe. Qatar Airways’ Chief Officer Cargo, Mr. Ulrich Ogiermann said, “We understand the intricacies of a seamless cool chain and always aim to provide value to our customers. Through this agreement with DoKaSch Temperature Solutions, we have now expanded our active container offering for customers, presenting our business partners with more options ...

Read More